Conference
NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA.
Abstract
3
Background: Previous reports suggested that AAT when combined with salvage RT following RP in patients may improve prostate cancer control outcomes. Methods: Post-RP patients with pT3pN0 or with pT2pN0 and positive margins who had or developed elevated PSA levels from 0.2 to 4.0 ng/ml were randomized on a phase III, double-blind, trial of RT + placebo (64.8 Gy in 36 fractions of 1.8 Gy) vs. RT + AAT (24 months bicalutamide, …
Authors
Shipley WU; Pugh SL; Lukka HR; Major P; Heney NM; Grignon DA; Sartor O; Patel M; Bahary J-P; Zietman AL
Volume
34
Pagination
pp. 3-3
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
January 10, 2016
DOI
10.1200/jco.2016.34.2_suppl.3
Conference proceedings
Journal of Clinical Oncology
Issue
2_suppl
ISSN
0732-183X